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Background: The prevalence of venous leg ulcers is as high as 1% to 1.5%, and the total costs of this disease are 1% of the
total annual health care budget in Western European countries. Treatment modalities are conservative or surgical.
Subfascial endoscopic perforating vein surgery (SEPS) combined with superficial vein ligation is performed in many
centers to address vein incompetence in patients with chronic venous leg ulcers. Several reports describe good healing and
low recurrence rates, although a randomized trial to compare surgical treatment including SEPS and treatment of the
superficial venous system to conservative modalities has never been performed. Therefore, a prospective, randomized,
multicenter trial was conducted to study whether ambulatory compression therapy with venous surgery is a better
treatment than just ambulatory compression therapy in venous leg ulcer patients.
Methods: Patients with an active (open) venous leg ulcer (CEAP C6) qualified for the study. The study consisted of two
treatment groups. All patients were treated by standardized ambulatory compression therapy, and half of the patients
received SEPS. Concomitant superficial venous incompetence was also treated in the second group. For allocation to both
treatment groups, each patient was assigned by a computer program at the randomization center. The primary goal of the
study was to compare the ulcer-free period during follow-up in both study groups. Secondary end points were ulcer
healing and recurrence rates.
Results: From April 1997 until January 2001, 200 ulcerated legs (170 patients) were included in the study in 12 centers
in The Netherlands. A total of 97 ulcers were allocated to the surgical group and 103 to the conservative group. Patient
characteristics were similar in the two treatment groups at baseline, with the exception of a higher proportion in the
conservative group of diabetes mellitus. Healing rates were 83% in the surgical group and 73% in the conservative group
(not significant; median time to healing, 27 months). Recurrence rates were the same in both treatment groups (22%
surgical vs 23% conservative). During follow-up of a mean of 29 months (median, 27 months) in the surgical group and
26 months (median, 24 months) in the conservative group, we found that in the surgical group, the ulcer-free rate was
72%, whereas in the conservative group this rate was 53% (P  .11; Mann-Whitney test). Patients with recurrent
ulceration or medially located ulcers in the surgical group had a longer ulcer-free period than those treated in the
conservative group (P .02 for both). A first-time ulcer and one of the centers also had a positive effect on the ulcer-free
period during follow-up (P < .001 and P  .02), independent of the treatment group. Deep vein incompetence did not
affect the ulcer-free period.
Conclusions: In conclusion, we suggest that patients with medial and/or recurrent ulceration should receive surgery
combined with ambulatory compression therapy. A dedicated center should provide care for those patients. ( J Vasc Surg
2006;44:563-71.)The prevalence of venous leg ulcers is as high as 1% to
1.5%.1,2 The total costs of the treatment of venous leg
ulcers are 1% of the total annual health care budget in
Western European countries.3 Treatment modalities are
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doi:10.1016/j.jvs.2006.04.053conservative or surgical. Conservative treatment includes
bed rest, leg elevation, local treatment, and compression
therapy. Surgical treatment consists of superficial and
perforating vein ablation and deep vein reconstruction.
Subfascial endoscopic perforating vein surgery (SEPS)
combined with superficial vein ligation is performed in
many centers to address vein incompetence in patients
with chronic venous leg ulcers. Several reports describe
good healing and low recurrence rates, although a ran-
domized trial to compare conservative and surgical treat-
ment modalities, including SEPS and, if necessary, treat-
ment of the superficial venous system, has never been
performed.4 Therefore, a prospective, randomized, mul-
ticenter trial was conducted to study whether ambula-
tory compression therapy with venous surgery is a better
treatment than just ambulatory compression therapy in
venous ulcer patients.
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Patients. Between April 1997 and January 2001, pa-
tients with an active (open) venous leg ulcer (CEAP C6)
Fig 1. Trial profile. SEPS, Subfasc
Table I. Patient characteristics
Variable Surgical (n
Sex (male:female) 2:3
Age, y (mean  SD) 64  1
Open ulcer, d (median) 120
First-time ulcer 31 (33%
Deep vein incompetence 49 (52%
Diabetes mellitus 6 (7%)
Deep vein thrombosis in medical history 29 (31%
Localization: medial 70 (74%
Ulcer size, mm2, median (range) 225 (4-7
NS, Not significant.were randomized in this study in 12 centers in The Neth-erlands. Both medial and lateral venous ulcers were in-
cluded. Exclusion criteria were arterial pathology (ankle-
brachial index 0.8), total or partial occlusion of the deep
doscopic perforating vein surgery.
) Conservative (n  102) P value (2)
2:3 NS
68  14 NS
120 NS
36 (35%) NS
57 (56%) NS
17 (17%) .05
31 (30%) NS
62 (61%) NS
260 (1-27,000) NS 94
5
)
)
)
)
800)venous system, former subfascial ligation of perforating
s.
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bility.
Patients with bilateral leg ulcers were included in the
study. The trial was approved by the ethics committees of
all 12 participating centers. All patients provided written
informed consent, and the study adhered to the Declara-
tion of Helsinki.
Methods. All patients were analyzed by medical his-
tory, physical examination, duplex ultrasonography, and
digital photographs. Both primary and secondary causes of
leg ulcers were included.
Both deep axial and segmental reflux were considered
to be deep vein incompetence (DVI) in this series. Reflux
was defined as retrograde flow more than 0.5 seconds after
calf compression or Vasalva maneuver. We did not discrim-
inate primary from secondary chronic venous disease.
Patients were stratified before randomization for three
factors: first-time ulcer or recurrent ulceration; presence or
absence of DVI; and center. Treatment consisted of two
treatment groups. For allocation to the treatment groups,
each patient was assigned by a computer program at an
independent randomization center. The randomization
took place within stratification groups. In case patients had
two ulcerated legs in the study, the legs were randomized
separately.
All patients were treated by standardized ambulatory
compression therapy, and half of the patients got SEPS,
combined, when indicated, with surgery of the superficial
venous system. Concomitant superficial venous incompe-
tence was treated in the second group by flush saphenopo-
pliteal ligation and/or saphenofemoral ligation and limited
stripping of the long saphenous vein from the groin to just
below the knee level. In most cases, the procedure can be
performed in an outpatient setting.
Ambulatory compression therapy was started directly
after randomization. Surgical treatment was performed
Table II. Median values of follow-up without ulcer for th
characteristics
Variable n
Male/female 77/119
Age (y)
55 52
55-75 81
75 63
4/4 mo† 93/82
First-time/recurrent ulcer 67/129
Deep vein incompetence (/) 90/106
Diabetes (/)‡ 170/23
Deep vein thrombosis (/)‡ 133/60
Medial/lateral ulcer 132/64
SFG (center) (/) 131/65
ANOVA, Analysis of variance; NS, not significant.
*P value from the Kruskal-Wallis test.
†The duration of ulceration before randomization was known for 175 legs.
‡The existence of diabetes and deep vein thrombosis was known in 193 legwithin five working days. SEPS was performed with anOlympus scope (Olympus, Hamburg, Germany), as de-
scribed elsewhere.10 A one-port technique and carbon
dioxide were used in all cases. All perforating veins were
interrupted by the use of hemoclips (Ligaclip; Ethicon
Endosurgery Amersfoort, The Netherlands) in a bloodless
area. The intermuscular septum was opened to reach per-
forators near the tibial crest in the lower part of the leg.
Patients were mobilized on the first postoperative day
and treated by dual-layer short-stretch ambulatory com-
pression therapy (Comprilan; Beiersdorf Medical, Almere,
The Netherlands) until the ulcer had healed. Therapeutic
elastic stockings (class II or III, depending on concomitant
Fig 2. Ulcer-free period per patient per 3 months in patients with
an ulcer present before randomization for shorter or longer than 4
months (P  .001; analysis of variance).
ire patient population according to various baseline
%
P value
(Mann-Whitney)
P value
(ANOVA)
62/69 NS NS
.06* NS
85
56
60
85/39 .001 .001
86/48 .001 .001
75/53 .08 NS
68/56 NS NS
71/50 NS NS
69/54 NS NS
74/42 .001 .02e entincompetence of the deep vein system) were prescribed
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described separately and in detail. Digital photographs
were taken at each visit. After randomization, patients were
seen on an outpatient basis after 1, 2, 3, 6, and 12 weeks
and then every 3 months. In cases of recurrence, patients
were seen immediately. Duplex ultrasonography was re-
peated 3 and 12 months after randomization.
Study end points. During follow-up, every ulcer was
scored as active (open) or healed. The primary goal of
the study was to compare the ulcer-free period during
follow-up in both study groups. The ulcer-free period was
Fig 3. The ulcer-free period per patient per 3 months in the
surgical and conservative groups (analysis of variance, P  .14)
Numbers along the horizontal axis represent legs still in follow-up
at the particular time points for the two groups.
Fig 4. Ulcer-free period per patient per 3 months in first-time
and recurrent ulceration patients (P  .001; analysis of variance).
Error bars represent standard errors of the mean.defined as the total percentage of days during follow-up apatient had no ulceration. Healing and recurrence rates
were assessed as secondary end points.
To evaluate the pattern of ulcer-free time, the follow-up
period from 0 to 36 months was divided into intervals of 3
months each. As long as a patient was under observation, it
was determined for each interval for how many days the
patient’s leg was ulcer free. The outcome was expressed as a
percentage of days, and the outcomewas considered valid and
was analyzedonly if the number of observationdayswithin the
periodwas sufficiently large (arbitrarily chosen as45days, ie,
half of the period). For example, if a patient were under
observation at the fifth interval for 60 days and if, during this
interval, his leg were ulcer free for 20 days, the analyzed
percentage for this interval would be 100  20/60  33%.
Each patient provided in this way a number of subsequent
interval percentages, and the means of these repeated mea-
surements are graphically displayed (Fig. 2, 3, 4, 5, 6).
Statistical analysis. The study power was set at 90% (	
 .10 and 
  .01), which indicated that with expected
healing and recurrence rates of 70% and 35% in the conser-
vative group and 85% and 10% in the surgical group,
inclusion of 100 ulcerated legs in each limb of the study was
necessary. The analysis was performed by intention to treat.
Overall analysis of the ulcer-free period was performed with
the Mann-Whitney test. To assess differences in both
groups during follow-up, repeated analyses were performed
with analysis of variance (ANOVA; SAS PROC MIXED;
SAS Institute, Cary, NC).
Role of the funding source. The study was sponsored
by Ziekenfondsraad/Ontwikkelingsgeneeskunde (Dutch
government; project OG98-045). The sponsor of the study
had no role in data collection, data analysis, data interpre-
tation, writing the report, or the decision to submit the
Fig 5. Ulcer-free period per patient per 3 months in patients
treated in one of the centers (SFG; P  .02; analysis of variance).paper for publication.
tence;
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From April 1997 until January 2001, 200 ulcerated
legs (170 patients) were included in the study in 12 centers
in The Netherlands. A total of 97 ulcers were allocated to
the surgical group and 103 to the conservative group. Four
patients were lost to follow-up directly after randomization
Fig 6. Ulcer-free period per patient per 3 months in patients with
a first-time ulcer and/or a medial ulcer in the surgical and conser-
vative groups (P  .045; analysis of variance).
Table III. Median values of follow-up without ulcer for t
baseline characteristics
Variable n Surgical
Total 196 72%
Male 77 74
Female 119 70
55 y 52 86
55-75 y 81 53
75 y 63 70
4 mo 63 88
4 mo 82 55
First-time ulcer 67 86
Recurrent ulcer 129 62
DVI 106 64
DVI 90 84
Diabetes 23 85
Diabetes 170 70
DVT 60 69
DVT 133 74
Medial ulcers 132 78
Lateral ulcers 64 49
SFG center 131 76
Other centers 65 53
ANOVA, Analysis of variance; NS, not significant; DVI, deep vein incompe(three in the surgical and one in the conservative group),without known cause, all in the same center. A total of 94
legs in the surgical and 102 legs in the conservative group
were analyzed (Fig 1). Patient characteristics were similar in
the two treatment groups at baseline, with the exception of
a higher proportion of diabetes mellitus in the conservative
group (Table I).
In the surgical group, 91 of 94 patients underwent a
SEPS procedure. Three patients were not operated on at
all. One patient experienced a myocardial infarction before
surgery, one developed deep vein occlusion, and one died
Fig 7. Cumulative healing rates according to randomized treat-
ment groups (P  .24). Tickmarks note the ends of follow-up of
patients.
rgical and conservative groups, according to various
nservative
P value
(Mann-Whitney)
P value
(ANOVA)
53% .11 .14
47 NS NS
55 NS NS
85 NS NS
68 NS NS
24 .008 .004
76 NS NS
11 .09 .09
86 NS NS
33 .05 .02
43 NS NS
72 NS NS
46 NS NS
53 NS NS
38 NS .01
69 NS NS
43 .02 .02
71 NS NS
72 NS NS
4 NS NS
DVT, deep vein thrombosis.he su
Cobefore surgery. Concomitant superficial incompetence was
DVT,
DVT,
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were treated only by a SEPS procedure, 29 had had super-
ficial vein surgery in the past. Only 11 patients (12%) had
isolated perforator vein incompetence. The mean number
of treated perforators was 3.7 (range, 0-8).
During follow-up, with a mean of 29 months (median,
27 months) in the surgical group and 26 months (median,
24 months) in the conservative group, 23 patients died
(this concerned 8 legs in the surgical group and 17 in the
conservative group; 2 patients had both legs in the trial).
None of the deaths was related to the ulcer or the allocated
treatment.
Age, sex, ulcer size, diabetes, deep vein thrombosis,
Table IV. Healing rates for the entire patient population
Variable n
Surgical/conservative 94/102
Male/female 77/119
Age (y)
55 52
55-75 81
75 63
4/4 mo 93/82
First-time/recurrent ulcer 67/129
DVI (/) 90/106
DM (/) 170/23
DVT (/) 133/60
Location: medial/lateral 132/64
Superficial vein surgery (/) 40/51
Ulcer size (250/250 mm2) 78/74
Center: SFG (/) 131/65
NS, Not significant; DVI, deep vein incompetence; DM, diabetes mellitus;
Table V. Healing rates for the surgical and conservative g
Variable n Surgical
Male 77 78
Female 119 86
Age (y)
55 52 84
55-75 81 75
75 63 93
4 mo 93 92
4 mo 82 77
First-time ulcer 67 87
Recurrence 129 81
DVI 106 82
DVI 90 84
DM 23 83
DM 170 83
DVT 60 86
DVT 133 81
Medial 132 87
Lateral 64 70
Ulcer size 250 mm2 78 88
Ulcer size 250 mm2 74 78
Center: SFG 131 86
Center: other 65 77
NS, Not significant; DVI, deep vein incompetence; DM, diabetes mellitus;and localization of the ulcer had no influence on theulcer-free period in this series (Table II). In contrast, the
number of days the ulcer existed before randomization
showed a positive effect on this primary end point. Patients
with ulcers existing 4 months or less before randomization
had a longer ulcer-free rate during follow-up (P  .001;
ANOVA; Fig 2). However, when we compared the surgical
with the conservative group for the primary end point
(ulcer-free days during follow-up), we found that in the
surgical group, the median ulcer-free period was 72%
(range, 0%-99%), and in the conservative group this was
53% (range, 0%-99%; P  .11; Mann-Whitney test). Simi-
larly, when individual patient follow-up was assessed, no
significant difference was found between the two groups (P
ding to various baseline characteristics
Healing rate (%) P value (log-rank)
83/73 NS
74/80 NS
79
78
76
91/65 .001
84/74 .001
78/77 .03
78/74 NS
79/73 .03
80/73 NS
80/78 NS
87/68 .001
82/68 .002
deep vein thrombosis.
s, according to various baseline characteristics
Conservative (%) P value (log-rank)
70 NS
74 NS
71 NS
80 NS
64 NS
91 NS
53 NS
80 NS
69 NS
74 NS
71 NS
71 NS
73 NS
61 NS
77 NS
72 .04
74 NS
86 NS
57 .01
79 NS
60 NS
deep vein thrombosis.accorroup
(%) .14; ANOVA; Fig 3).
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fied for first-time ulcer vs recurrent ulceration, presence or
absence of DVI, and center. Of these strata, a first-time
ulcer and one of the centers had a positive effect on the
ulcer-free period during follow-up for both study groups (P
 .001 [Fig 4] and P  .02 [Fig 5]). DVI did not affect this
primary end point. Patients with recurrent ulceration
treated in the surgical group also had a higher ulcer-free
rate during follow-up (62% vs 33% in the conservative
group; P  .02; ANOVA). Also, medially located ulcers
had this same advantage in the surgical group (78% vs 43%
in the conservative group; P  .02; ANOVA). Patients
older than 75 years had a higher ulcer-free rate in the
surgical group (70% vs 24% in the conservative group; P 
.004; ANOVA), but analysis showed that this was related to
recurrent ulceration (Table III). Considered on a per-
patient basis, patients with recurrent ulceration and/or
medially located ulcers in the surgical group also had a
higher ulcer-free rate during follow-up than those treated
in the conservative group (P  .045; ANOVA; Fig 6).
Ulcer healing rates were 83% and 73% in the surgical
and conservative groups, respectively (not significant; Fig
7). The median and mean time to ulcer healing were 11 and
4.2 months in the surgical group and 15 and 5.7 months in
the conservative group (not significant). Healing rates in
both groups were significantly influenced by first-time ul-
cers (P .001), ulcers of more than 4 months’ duration (P
 .001), ulcer size (P  .001), DVI (P  .03), deep vein
thrombosis in the medical history (P  .03), and center (P
 .002; Table IV). Medial and recurrent ulcers also had
significantly higher healing rates in the surgical group (P
.04 and P  .01) compared with the conservative group
(Table V). Finally, when we compared the surgical and
conservative treatment groups, no statistical difference was
found in recurrence rates (22% vs 23%; Fig 8), and the only
Fig 8. Cumulative recurrence rates according to randomized
treatment groups (not significant). Tickmarks note the ends of
follow-up of patients.parameter that influenced recurrence rates was a first-timeulcer. First-time ulcers had significantly lower recurrence
rates than recurrent ulcers (P  .01; Table VI).
DISCUSSION
Treatment modalities for patients with chronic venous
disease may be conservative or surgical. Conservative treat-
ment is reported to provide good healing rates in mixed
patient groups (C2-C6), but recurrence rates can be high
(55%-100%) and are dependent on patient compliance.5
Since the introduction of SEPS by Hauer6 in 1985, several
reports have claimed good healing and reduced recurrence
rates in patients treated with this method. However, pub-
lications involving SEPS describe mixed patient groups and
comparison to different treatments,4,7-9 and just one pro-
spective, randomized trial has been performed. Pierik et
al10 compared the Linton procedure with SEPS. Despite
the small patient number in that study, SEPS was recom-
mended because of the high complication rate after the
Linton procedure and the comparable healing and recur-
rence rates between the two treatments. Thus, currently,
circumstantial evidence suggests that surgical treatment of
incompetent superficial and perforating veins improves
healing rates and decreases recurrences when compared
with nonsurgical treatment in venous ulcer patients.
To our knowledge, this article describes the first mul-
ticenter, prospective, randomized trial investigating SEPS
in combination with treatment of the incompetent super-
ficial venous system in patients with venous ulcers. In
addition to common end points involving ulcer treatment,
such as healing and recurrence rates, we describe another
primary end point for this study. We postulate that the
ulcer-free period during follow-up gives us more insight
into the actual course of the disease, because recurrence is
dependent on healing. Additionally, healing and recurrence
rates do not show the amount of time that an ulcer is active.
Therefore, we used healing and recurrence rates as second-
ary end points in this study.
In this prospective study, we found similar high ulcer-free
rates in the surgical and conservative groups (72% vs 53%,
respectively; P .14; ANOVA). However, in subgroup anal-
ysis, we found that medial ulcers benefited significantly (P 
.02) from surgery, whereas lateral ulcers did not. de Rijcke et
al11 reported poor results with SEPS procedures performed
on the lateral aspect of the lower leg in a small series. The
authors claimed that these poor results of lateral procedures
may be explained by alignment of perforating veins along the
intermuscular septa, which requires full septa dissection on the
lateral side if lateral crural perforating veins are to be treated
effectively.12 In our series, full septum dissections were per-
formed on the medial aspects of the lower leg, but not on the
lateral sides, and this may have influenced the outcome on all
end points. Regardless, medial and lateral leg ulcers were
equally distributed in the two study groups. Patients with
recurrent ulceration also had a longer ulcer-free period during
follow-up in the surgical group. Thus, 168 (86%) of 196
patients in our series had either a medial or recurrent ulcer,
and we conclude that in most cases, SEPS surgery can be
beneficial for patients with chronic venous leg ulcers. In con-
DVT,
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ulcer-free period (73% vs 61%;P .09). This can be explained
by the fact that after surgery, all patients in the surgical group
had a treated or competent superficial system.
During randomization, we stratified for center, recur-
rent ulceration, and DVI. In analysis of the entire patient
population, we found that in one of the centers patients had
a longer ulcer-free period when compared with the other
centers. This center is known to be a dedicated center for
the treatment of venous diseases and contributed more
than half of the patients in the study. Dedicated, multidis-
ciplinary ulcer care centers have previously been reported to
be associated with good healing rates.13,14 Patients with a
first-time ulcer also had a longer ulcer-free period during
follow-up when compared with patients with recurrent
ulceration. A possible explanation is that recurrent ulcer-
ation may be seen as an advanced stage of chronic venous
disease when compared with first-time ulceration, and,
thus, the natural history of a first-time ulcer may be better
than that of recurrent ulceration. Finally, DVI did not
influence the primary end point in this series.
Demographics of the randomized population showed a
higher proportion of patients with diabetes mellitus in the
conservative group (17% vs 7%; P .05). However, analysis
of the effect of diabetes mellitus on all end points demon-
strated no significant influence, possibly because of the
small number of patients in this series.
Healing rates (83% in the surgical and 73% in the
conservative group; not significant) were comparable to
rates previously reported in the literature. However, recur-
rence rates in the surgical group were much higher than
anticipated (22%). A possible cause for the high recurrence
rates is the quality of the SEPS procedure. The number of
persistent or new incompetent perforating veins after a
SEPS procedure and the recurrence of incompetence of the
superficial system could influence healing and recurrence
rates. Further analysis to evaluate the effect of the quality of
Table VI. Recurrence rates for the entire patient populati
Variable n
Surgical/conservative 77/72
Male/female 56/93
Age (y)
55 40
55-75 62
75 47
4/4 mo 83/52
First-time ulcer/recurrence 56/93
DVI (/) 69/80
DM (/) 129/17
DVT (/) 103/43
Medial/lateral 102/47
Superficial vein surgery (/) 40/51
Ulcer size (250/250 mm2) 68/50
Center: SFG (/) 108/44
NS, Not significant; DVI, deep vein incompetence; DM, diabetes mellitus;the procedures has to be performed.To conclude, we suggest that patients with medial
and/or recurrent ulceration could benefit from surgery
combined with ambulatory compression therapy. Addi-
tionally, a dedicated center should provide the care for such
patients.
Irwin Toonder, RVT, performed duplex imaging; Cora
Hazelzet provided secretarial support. Participating centers
included Sint Franciscus Gasthuis, Rotterdam; Erasmus
Medisch Centrum, lokatie Dijkzigt, Rotterdam; Reinier de
Graaf Groep, lokatie Reinier de Graaf Gasthuis, Delft; VU
Medisch Centrum, Amsterdam; Meander Medisch Cen-
trum, Amersfoort; Stichting Het van Weel Bethesda Ziek-
enhuis, Dirksland; Havenziekenhuis, Rotterdam; Ikazia
Ziekenhuis, Rotterdam; Medisch Centrum Rijnmond
Zuid, lokatie St Clara Ziekenhuis, Rotterdam; Vlietland
Ziekenhuis, lokatie Schiedam, Schiedam; Vlietland Zieken-
huis, lokatie Vlaardingen, Vlaardingen; and Albert
Schweitzer Ziekenhuis, lokatie Dordwijk, Dordrecht.
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DrGent and colleagues are to be commended for performing the
first prospective, randomized study involving subfascial endoscopic
perforator surgery (SEPS). Unfortunately, this study cannot resolve
the controversy regarding whether SEPS is beneficial. In this article,
SEPS was frequently not a stand-alone surgery, but was combined
with superficial surgery in 51 of 91 limbs, and 40 of 91 limbs had had
previous superficial vein surgery performed. Only 11 patients had
isolated perforator vein incompetence. Thus, this study, as pointed
out in the title, is really a comparisonbetweennonsurgical and surgical
treatment. A few previous articles have indicated that venous surgery
shortens the time to heal and decreases the recurrence rate of ulcer-
ated limbs. This study found, disappointingly, no statistical differences
in the healing rate, ulcer recurrence rate, or ulcer-free period. Thus,
surgery was not beneficial for this group of patients. By stratifying the
material, the results indicate that a subgroup with medial and/or
recurrent ulcers would perhaps benefit from surgery. Perhaps a mul-
tivariate Cox model test would have shed further light on different
parameters.
As secondary end points, the healing rate and the ulcer recur-
rence–free rate analyzed ad modum Kaplan-Meier were used.
These are appropriate methods according to the reporting stan-
dards. To use the “ulcer-free” period is questionable. It includes
time to heal and time to ulcer recurrence, but it is also much
dependent on the length of observation and on deaths among theFrom serial studies of ulcerated limbs treated by SEPS, we
know that ulcer recurrence is lower in limbs with primary reflux as
compared with those with postthrombotic disease. It is a pity that
this material is not described by the CEAP classification, which
would better inform the reader of the composition of the patient
material. We know that deep vein reflux was present in about half
of each group, but was it segmental or axial, primary or secondary?
A history of deep vein thrombosis was found in one third of
patients, but how many had findings supporting postthrombotic
changes? Many in the surgically treated group had had previous
surgery. Had limbs randomized to conservative treatment had any
previous interventions? Perhaps there were significant discrepan-
cies in some of these aspects, and this may help explain the lack of
difference in outcome. There is no information of the status of the
perforators before and after SEPS, and this supports that the
procedure was not adequately performed.
Thus, the controversy continues regarding the importance of
perforators and their treatment. SEPS has presently largely been
replaced by ultrasound-guided sclerotherapy and laser or radiofre-
quency ablation of the perforators and is mostly used only as a last
resort. This article suggests that limbs with medial and/or recur-
rent ulcer with no superficial reflux (previously operated on or not)
may benefit from SEPS, and these limbs may be the objective of a
future prospective study.
